These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 1305621)

  • 1. Successful treatment of multiple sclerosis with magnetic fields.
    Sandyk R
    Int J Neurosci; 1992 Oct; 66(3-4):237-50. PubMed ID: 1305621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic fields in the therapy of parkinsonism.
    Sandyk R
    Int J Neurosci; 1992 Oct; 66(3-4):209-35. PubMed ID: 1305620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid normalization of visual evoked potentials by picoTesla range magnetic fields in chronic progressive multiple sclerosis.
    Sandyk R
    Int J Neurosci; 1994 Aug; 77(3-4):243-59. PubMed ID: 7814217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetic fields normalize visual evoked potentials and brainstem auditory evoked potentials in multiple sclerosis.
    Sandyk R; Derpapas K
    Int J Neurosci; 1993 Feb; 68(3-4):241-53. PubMed ID: 8063529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resolution of longstanding symptoms of multiple sclerosis by application of picoTesla range magnetic fields.
    Sandyk R; Iacono RP
    Int J Neurosci; 1993 Jun; 70(3-4):255-69. PubMed ID: 8063544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pineal-hypothalamic tract mediation of picotesla magnetic fields in the treatment of neurological disorders.
    Jacobson JI
    Panminerva Med; 1994 Dec; 36(4):201-5. PubMed ID: 7603740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple sclerosis: improvement of visuoperceptive functions by picoTesla range magnetic fields.
    Sandyk R; Iacono RP
    Int J Neurosci; 1994; 74(1-4):177-89. PubMed ID: 7928104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Further observations on the effects of external picoTesla range magnetic fields on visual memory and visuospatial functions in multiple sclerosis.
    Sandyk R
    Int J Neurosci; 1994 Aug; 77(3-4):203-27. PubMed ID: 7814214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement by picoTesla range magnetic fields of perceptual-motor performance and visual memory in a patient with chronic progressive multiple sclerosis.
    Sandyk R; Iacono RP
    Int J Neurosci; 1994 Sep; 78(1-2):53-66. PubMed ID: 7829292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields.
    Sandyk R
    Int J Neurosci; 1995 Jun; 82(3-4):223-42. PubMed ID: 7558651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resolution of dysarthria in multiple sclerosis by treatment with weak electromagnetic fields.
    Sandyk R
    Int J Neurosci; 1995 Nov; 83(1-2):81-92. PubMed ID: 8746751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A potential multiple resonance mechanism by which weak magnetic fields affect molecules and medical problems: the example of melatonin and experimental "multiple sclerosis".
    Persinger MA
    Med Hypotheses; 2006; 66(4):811-5. PubMed ID: 16321472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolution of Lhermitte's sign in multiple sclerosis by treatment with weak electromagnetic fields.
    Sandyk R; Dann LC
    Int J Neurosci; 1995 Apr; 81(3-4):215-24. PubMed ID: 7628912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naltrexone attenuates the antiparkinsonian effects of picoTesla range magnetic fields.
    Sandyk R; Iacono RP
    Int J Neurosci; 1994 Sep; 78(1-2):111-22. PubMed ID: 7829285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute tumefactive demyelinating lesions in a pediatric patient with known diagnosis of multiple sclerosis: review of the literature and treatment proposal.
    Dastgir J; DiMario FJ
    J Child Neurol; 2009 Apr; 24(4):431-7. PubMed ID: 19189932
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous immunoglobulin treatment following the first demyelinating event suggestive of multiple sclerosis: a randomized, double-blind, placebo-controlled trial.
    Achiron A; Kishner I; Sarova-Pinhas I; Raz H; Faibel M; Stern Y; Lavie M; Gurevich M; Dolev M; Magalashvili D; Barak Y
    Arch Neurol; 2004 Oct; 61(10):1515-20. PubMed ID: 15477504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple sclerosis.
    Blumenthal S
    Radiol Technol; 2006; 77(4):309-21, quiz 322-5. PubMed ID: 16543484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of micrographia in Parkinson's disease by application of picoTesla range magnetic fields.
    Sandyk R; Iacono RP
    Int J Neurosci; 1994 Jul; 77(1-2):77-84. PubMed ID: 7989163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG).
    Jacobs LD; Cookfair DL; Rudick RA; Herndon RM; Richert JR; Salazar AM; Fischer JS; Goodkin DE; Granger CV; Simon JH; Alam JJ; Bartoszak DM; Bourdette DN; Braiman J; Brownscheidle CM; Coats ME; Cohan SL; Dougherty DS; Kinkel RP; Mass MK; Munschauer FE; Priore RL; Pullicino PM; Scherokman BJ; Whitham RH
    Ann Neurol; 1996 Mar; 39(3):285-94. PubMed ID: 8602746
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term beneficial effects of weak electromagnetic fields in multiple sclerosis.
    Sandyk R
    Int J Neurosci; 1995 Nov; 83(1-2):45-57. PubMed ID: 8746748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.